Fluticasone Propionate
Product Images NDC 54868-5337

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 54868-5337). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Image (260483b0 A145 4655 9d44 1d3069551c4d 01)

FDA Label Image

Table 1 (260483b0 A145 4655 9d44 1d3069551c4d 02)

The given text is a table showing various drug-related adverse events related to the skin for patients who were given Fluticasone Once, Fluticasone Twice, and Vehicle Twice. The table has details about the number of patients observed for the drug effect and the type of skin reaction. The adverse events include skin infections, eczema, viral warts, herpes simplex, impetigo, atopic dermatitis, exacerbation of eczema, erythema, burning, stinging, skin irritation, pruritus, exacerbation of pruritus, folliculitis, blisters, and dryness of the skin.*

FDA Label Image

Table 2 (260483b0 A145 4655 9d44 1d3069551c4d 03)

Table 2 summarizes the adverse events encountered in a pediatric open-label trial where Fluticasone was administered twice a day. The table includes adverse events such as Buting, Dusky Erythema, Erythematous rash, Fadal and Nor-fadal telangiectasia, and Urticaria. For additional details, one may refer to the accompanying text. The number of participants in the trial was 51.*

FDA Label Image

Table 3 (260483b0 A145 4655 9d44 1d3069551c4d 04)

This text is a table showing the physician's assessment of clinical response to Fluticasone propionate cream. It includes percentages of patients who are rated as having excellent, good, fair, poor, or worse response based on their physician's assessment.*

FDA Label Image

Table 4 (260483b0 A145 4655 9d44 1d3069551c4d 05)

This appears to be a table showing improvements in clinical signs with the use of fluticasone propionate cream compared to a vehicle (likely a placebo cream). The clinical signs being measured appear to be Erythema, Tackling, and Scaling. However, further context is needed to understand the significance of the values.*

FDA Label Image

Table 5 (260483b0 A145 4655 9d44 1d3069551c4d 06)

This appears to be a table showing the physician's assessment of clinical response to two different creams that contain the medication fluticasone propionate, with different dosing instructions. The table includes four columns labeled Study 1 and Study 2 for each of the two creams, with sample sizes for each column. The rows indicate the level of response, ranging from Excellent to Poor or Worse. The percentage of patients in each cell corresponds to the proportion of patients who received that rating for that dosing regimen in that study.*

FDA Label Image

Table 6 (260483b0 A145 4655 9d44 1d3069551c4d 07)

This is a table that provides mean improvements over baseline for clinical signs and symptoms from two studies using different strengths of Futicasone Propionate cream. The table shows improvements in Erythema, Pruritus, Thickening, Lichenification, Vesiculation and Crusting. The first column mentions a 0.05% cream, applied once daily, and the second column mentions a 0.05% cream, applied twice daily. The table contains four studies (Stdy 1, Sty 2, Study T, Study 2).*

FDA Label Image

Image Of Package Label (5337)

This appears to be a package label for Fluticasone 6.65% cream, distributed by Physicians Total Care with batch number 0060 and expiration date 06/18. The NDC (National Drug Code) number is also listed as 54868-5337-0. However, the "I S3370360500" text is not clear and its meaning is unclear.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.